Tens of thousands of Americans experience sudden hearing loss each year. Now, a biotech company called Frequency Therapeutics is hoping to be the first to make it to market with a drug it claims will use patients' own biology to restore what was lost. CBS News national correspondent Jericka Duncan reports.
#news #health #hearing
Each weekday morning, "CBS Mornings” co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.
Subscribe to “CBS Mornings” on KZitem: / cbsmornings
Watch CBS News: cbsn.ws/1PlLpZ7c
Download the CBS News app: cbsn.ws/1Xb1WC8
Follow "CBS Mornings" on Instagram: bit.ly/3A13OqA
Like "CBS Mornings" on Facebook: bit.ly/3tpOx00
Follow "CBS Mornings" on Twitter: bit.ly/38QQp8B
Subscribe to our newsletter: cbsn.ws/1RqHw7T
Try Paramount+ free: bit.ly/2OiW1kZ
For video licensing inquiries, contact: licensing@veritone.com
Негізгі бет Experimental, early-stage drug aims to restore hearing
Пікірлер: 61